pharma news today obesity drugs glp-1 october 2025 President Trump announced the popular weight loss would soon be more accessible to millions of Americans at a cost of only $50 per month. MORE BELOW⬇️ The future of GLP-1s: Cost,

More recently Pfizer has reported development of a humanized GHR monoclonal antagonist antibody (RN172), which blocked GH signaling in vitro and reduced IGF1 production in monkeys following a single-intravenous injection

Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic

Ipamorelin, the first selective growth hormone secretagogue Background source for ipamorelin selectivity and GH-secretagogue mechanism

A serum B12 level between 300 pg/mL and 900 pg/mL is considered normal and levels above 900 pg/mL are considered high

El running es un ejercicio de impacto que afecta mucho a las articulaciones: si no se cuidan, pueden suponer una lesin extrema

Circulation and degradation of GIP and GLP-1